Cargando…
Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis
BACKGROUND: Multiple Biomarkers have recently been shown to be elevated in COVID-19, a respiratory infection with multi-organ dysfunction; however, information regarding the prognostic value of cardiac biomarkers as it relates to disease severity and cardiac injury are inconsistent. RESEARCH QUESTIO...
Autores principales: | Dawson, Desiree, Dominic, Paari, Sheth, Aakash, Modi, Malak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336705/ https://www.ncbi.nlm.nih.gov/pubmed/32702736 http://dx.doi.org/10.21203/rs.3.rs-34729/v1 |
Ejemplares similares
-
Prognostic value of cardiac biomarkers in COVID-19 infection
por: Sheth, Aakash, et al.
Publicado: (2021) -
Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Mustafa, Usman, et al.
Publicado: (2019) -
The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19
por: Zwaenepoel, Bert, et al.
Publicado: (2021) -
Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
por: Thotamgari, Sahith Reddy, et al.
Publicado: (2022) -
Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease
por: Yu, Jia-Sheng, et al.
Publicado: (2021)